ÈESKÁ UROLOGIE / CZECH UROLOGY – 1 / 2018

26 Ces Urol 2018; 22(1): 14–26 PØEHLEDOVÝ ÈLÁNEK 27. Vickers AJ, Cronin AM, Bjork T, et al. Prostate specific antigen concentration at age 60 and death or metastasis from prostate cancer: case-control study. BMJ 2010; 341: c4521. 28. Carlsson S, Assel M, Sjoberg D, et al. Influence of prostate specific antigen levels at age 60 on benefits and harms of prostate cancer screening: population based cohort study. BMJ 2014; 348: g2206. 29. Aus G, Bergdahl S, Lodding P, Lilja H, Hugosson J. Prostate cancer screening decreases the absolute risk of being diagnosed with advanced prostate cancer – results from a prospective, population-based randomized controlled trial. Eur Urol 2007; 51: 659–664. 30. Hayes JH, Barry MJ. Screening for prostate cancer with the prostate-specific antigen test: a review of current evidence. JAMA 2014; 311: 1143–1149. 31. Draisma G, Etzioni R, Tsodikov A, et al. Lead time and overdiagnosis in prostate-specific antigen screening: importance of methods and context. J Natl Cancer Inst 2009; 101: 374–383. 32. Rosario DJ, Lane JA, Metcalfe C, et al. Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: prospective evaluation within ProtecT stud. BMJ 2012; 344: d7894. 33. Chou R, Croswell JM, Dana T, et al. Screening for prostate cancer: a review of the evidence for the U.S. Preventive Task Force. Ann Intern Md 2011; 155: 762–771. 34. Wilt TJ, Brawer MK, Jones KM. Radical prostatectomy versus observation for localized prostate cancer. N Engl J Med 2012; 367: 582. 35. Vickers AJ, Sjoberg DD, Ulmert D, et al. Empirical estimates of prostate cancer overdiagnosis by age and prostate-specific antigen. BMC Med 2014; 12: 26. 36. Gulati R, Tsodikov A, Wever EM, et al. The impact of PLCO control arm contamination on perceived PSA screening efficacy. Cancer Causes Control 2012; 23: 827–835. 37. http://www.linkos.cz/prevence-a-skrining/onkoprevence-pro-ceskou-republiku-1/. 38. www.mamo.cz. 39. www.kolorektum.cz. 40. www.cervix.cz. 41. http://reporting.uzis.cz/. 42. https://www.uzis.cz/registry-nzis/nor. ?? Diagnostika karcinomu prostaty pomocí fúzní biopsie ?? Monorova choroba penisu ?? Porovnání detekce signifikantního a nesignifikantního karcinomu pomocí systematické a cílené fúzní MRI/TRUS biopsie prostaty ?? Vliv denzity a velikosti litiázy na výsledek flexibilní ureterorenoskopie ?? Primární Ewingùv sarkom ledviny u mladé ženy Do Èeské urologie è. 2 / 2018 pøipravujeme